Related Experiment Video
Updated: Jul 26, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Restored autophagy is protective against PAK3-induced cardiac dysfunction
Andrea Ruiz-Velasco1, Rida Raja1, Xinyi Chen1
1Faculty of Biology, Medicine, and Health, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Abstract:
Despite the development of clinical treatments, heart failure remains the leading cause of mortality. We observed that p21-activated kinase 3 (PAK3) was augmented in failing human and mouse hearts. Furthermore, mice with cardiac-specific PAK3 overexpression exhibited exacerbated pathological remodeling and deteriorated cardiac function. Myocardium with PAK3 overexpression displayed hypertrophic growth, excessive fibrosis, and aggravated apoptosis following isoprenaline stimulation as early as two days. Mechanistically, using cultured cardiomyocytes and human-relevant samples under distinct stimulations, we, for the first time, demonstrated that PAK3 acts as a suppressor of autophagy through hyper-activation of the mechanistic target of rapamycin complex 1 (mTORC1). Defective autophagy in the myocardium contributes to the progression of heart failure. More importantly, PAK3-provoked cardiac dysfunction was mitigated by administering an autophagic inducer. Our study illustrates a unique role of PAK3 in autophagy regulation and the therapeutic potential of targeting this axis for heart failure.
Insights
Heart failure is a leading cause of death. This study reveals p21-activated kinase 3 (PAK3) worsens heart failure by suppressing autophagy, offering a new therapeutic target.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cellular Signaling
Background:
- Heart failure remains a major global health challenge with limited effective treatments.
- P21-activated kinase 3 (PAK3) has been identified as upregulated in failing hearts.
- The precise role of PAK3 in cardiac pathophysiology is not fully understood.
Purpose of the Study:
- To investigate the role of PAK3 in the progression of heart failure.
- To elucidate the molecular mechanisms by which PAK3 affects cardiac function.
- To explore the therapeutic potential of targeting the PAK3-autophagy axis in heart failure.
Main Methods:
- Cardiac-specific PAK3 overexpression in mouse models.
- Assessment of cardiac function and pathological remodeling.
- Investigation of autophagy regulation in cardiomyocytes and human samples.
- Pharmacological intervention with an autophagic inducer.
Main Results:
- Cardiac-specific PAK3 overexpression led to exacerbated cardiac dysfunction, hypertrophy, fibrosis, and apoptosis.
- PAK3 was found to suppress autophagy by hyper-activating mTORC1.
- Inhibition of PAK3-mediated autophagy suppression improved cardiac function in vivo.
- Targeting the PAK3-autophagy pathway demonstrated therapeutic efficacy.
Conclusions:
- PAK3 plays a critical role in promoting heart failure progression by inhibiting myocardial autophagy.
- PAK3 acts as a negative regulator of autophagy via mTORC1 signaling.
- Modulating the PAK3-autophagy axis represents a promising therapeutic strategy for heart failure.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
PI3K/mTOR/AKT Signaling Pathway

